Ilya Zubkov
Stock Analyst at Freedom Capital Markets
(2.53)
# 2,973
Out of 5,074 analysts
24
Total ratings
52.9%
Success rate
4.4%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Reiterated: Hold | $5 | $3.87 | +29.20% | 2 | Aug 11, 2026 | |
| ILMN Illumina | Downgraded: Hold | $185 | $282.86 | -34.60% | 1 | Aug 5, 2026 | |
| VMD Viemed Healthcare | Downgraded: Hold | $11 | $9.75 | +12.82% | 1 | Aug 5, 2026 | |
| SMTI Sanara MedTech | Downgraded: Hold | $35 | $32.77 | +6.81% | 2 | Aug 3, 2026 | |
| JNJ Johnson & Johnson | Upgraded: Buy | $280 | $257.78 | +8.62% | 1 | Jul 16, 2026 | |
| NAGE Niagen Bioscience | Initiated Coverage: Buy | $9 | $2.47 | +264.37% | 1 | Jul 6, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Initiated Coverage: Buy | $27 | $11.07 | +143.90% | 1 | Jul 2, 2026 | |
| ATYR aTyr Pharma | Upgraded: Buy | $3.5 | $0.1723 | +1,931.34% | 1 | May 20, 2026 | |
| ATRA Atara Biotherapeutics | Upgraded: Hold | $10 | $9.35 | +6.95% | 1 | May 18, 2026 | |
| AMGN Amgen | Upgraded: Buy | $375 | $438.34 | -14.45% | 1 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $245 | $240.98 | +1.67% | 1 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $6.67 | +79.91% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $11.89 | +34.57% | 1 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $116 | $87.81 | +32.10% | 1 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $3.14 | +536.44% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $2.08 | n/a | 1 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $14 → $37 | $18.56 | n/a | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $4.20 | n/a | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $8.37 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $27.32 | n/a | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $2.14 | n/a | 1 | Mar 18, 2025 |
Sionna Therapeutics
Aug 11, 2026
Reiterated: Hold
Price Target: $5
Current: $3.87
Upside: +29.20%
Illumina
Aug 5, 2026
Downgraded: Hold
Price Target: $185
Current: $282.86
Upside: -34.60%
Viemed Healthcare
Aug 5, 2026
Downgraded: Hold
Price Target: $11
Current: $9.75
Upside: +12.82%
Sanara MedTech
Aug 3, 2026
Downgraded: Hold
Price Target: $35
Current: $32.77
Upside: +6.81%
Johnson & Johnson
Jul 16, 2026
Upgraded: Buy
Price Target: $280
Current: $257.78
Upside: +8.62%
Niagen Bioscience
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $2.47
Upside: +264.37%
Arcturus Therapeutics Holdings
Jul 2, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $11.07
Upside: +143.90%
aTyr Pharma
May 20, 2026
Upgraded: Buy
Price Target: $3.5
Current: $0.1723
Upside: +1,931.34%
Atara Biotherapeutics
May 18, 2026
Upgraded: Hold
Price Target: $10
Current: $9.35
Upside: +6.95%
Amgen
May 7, 2026
Upgraded: Buy
Price Target: $375
Current: $438.34
Upside: -14.45%
May 1, 2026
Upgraded: Buy
Price Target: $245
Current: $240.98
Upside: +1.67%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $6.67
Upside: +79.91%
Apr 6, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $11.89
Upside: +34.57%
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $116
Current: $87.81
Upside: +32.10%
Mar 30, 2026
Upgraded: Buy
Price Target: $20
Current: $3.14
Upside: +536.44%
Sep 30, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $2.08
Upside: n/a
Aug 11, 2025
Upgraded: Buy
Price Target: $14 → $37
Current: $18.56
Upside: n/a
Aug 4, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $4.20
Upside: n/a
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $13
Current: $8.37
Upside: n/a
Jul 1, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $27.32
Upside: n/a
Mar 18, 2025
Reiterated: Buy
Price Target: $13
Current: $2.14
Upside: n/a